| Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study G Buckland, CA González, A Agudo, M Vilardell, A Berenguer, P Amiano, ... American journal of epidemiology 170 (12), 1518-1529, 2009 | 412 | 2009 |
| Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder I Cusco, A Medrano, B Gener, M Vilardell, F Gallastegui, O Villa, ... Human molecular genetics 18 (10), 1795-1804, 2009 | 138 | 2009 |
| Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes M Vilardell, A Rasche, A Thormann, E Maschke-Dutz, LA Pérez-Jurado, ... BMC genomics 12, 1-16, 2011 | 133 | 2011 |
| Human Embryonic Stem Cell Derived Hepatocyte-Like Cells as a Tool for In Vitro Hazard Assessment of Chemical Carcinogenicity R Yildirimman, G Brolén, M Vilardell, G Eriksson, J Synnergren, ... Toxicological Sciences 124 (2), 278-290, 2011 | 75 | 2011 |
| Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models TY Doktorova, R Yildirimman, M Vinken, M Vilardell, T Vanhaecke, ... Carcinogenesis 34 (6), 1393-1402, 2013 | 56 | 2013 |
| DNA–methylome analysis of mouse intestinal adenoma identifies a tumour-specific signature that is partly conserved in human colon cancer C Grimm, L Chavez, M Vilardell, AL Farrall, S Tierling, JW Böhm, P Grote, ... PLoS genetics 9 (2), e1003250, 2013 | 56 | 2013 |
| Array-CGH in patients with Kabuki-like phenotype: identification of two patients with complex rearrangements including 2q37 deletions and no other recurrent aberration I Cuscó, M Del Campo, M Vilardell, E González, B Gener, E Galán, ... BMC medical genetics 9, 1-14, 2008 | 49 | 2008 |
| Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1 B Tazon-Vega, M Vilardell, L Perez-Oller, E Ars, P Ruiz, O Devuyst, ... Nephrology Dialysis Transplantation 22 (6), 1567-1577, 2007 | 40 | 2007 |
| GCAT| Genomes for life: a prospective cohort study of the genomes of Catalonia M Obón-Santacana, M Vilardell, A Carreras, X Duran, J Velasco, ... BMJ open 8 (3), e018324, 2018 | 38 | 2018 |
| Transcriptome profile in Williams–Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits A Antonell, M Vilardell, LA Pérez Jurado Human genetics 128, 27-37, 2010 | 31 | 2010 |
| Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model? TY Doktorova, R Yildirimman, L Ceelen, M Vilardell, T Vanhaecke, ... EXCLI journal 13, 623, 2014 | 27 | 2014 |
| Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020 R Clèries, RM Rooney, M Vilardell, JA Espinàs, T Dyba, JM Borras Clinical and Translational Oncology 20, 313-321, 2018 | 25 | 2018 |
| Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective R Herwig, H Gmuender, R Corvi, KM Bloch, A Brandenburg, J Castell, ... Archives of toxicology 90, 2215-2229, 2016 | 19 | 2016 |
| Missing data imputation and synthetic data simulation through modeling graphical probabilistic dependencies between variables (ModGraProDep): An application to breast cancer … M Vilardell, M Buxó, R Clèries, JM Martínez, G Garcia, A Ameijide, R Font, ... Artificial intelligence in medicine 107, 101875, 2020 | 14 | 2020 |
| Validation of Transcriptomics-Based In Vitro Methods R Corvi, M Vilardell, J Aubrecht, A Piersma Validation of Alternative Methods for Toxicity Testing, 243-257, 2016 | 11 | 2016 |
| Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona A Ameijide, R Clèries, M Carulla, M Buxó, R Marcos-Gragera, ... Clinical and Translational Oncology 21, 1014-1025, 2019 | 9 | 2019 |
| WebSurvCa: estimación vía web de las probabilidades de fallecimiento y de supervivencia de una cohorte R Clèries, A Ameijide, M Buxó, M Vilardell, JM Martínez, F Alarcón, ... Gaceta Sanitaria 32, 492-495, 2019 | 5 | 2019 |
| Package ‘varcompci’ S Civit, M Vilardell, A Hess, Z Matthew, Y Ge, A Caballe, MS Civit Food Control 12, 119-125, 2013 | 5 | 2013 |
| WebSurvCa: web-based estimation of death and survival probabilities in a cohort R Clèries, A Ameijide, M Buxó, M Vilardell, JM Martínez, F Alarcón, ... Gaceta Sanitaria 32 (5), 492-495, 2018 | 4 | 2018 |
| An integrative computational analysis provides evidence for FBN1-associated network deregulation in trisomy 21 M Vilardell, S Civit, R Herwig Biology Open 2 (8), 771-778, 2013 | 4 | 2013 |
Sergi Civit-VivesAssistant professor of Statistics, University of BarcelonaAdresă de e-mail confirmată pe ub.edu
